Clinical Trial Update: Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating dacomitinib (PF-00299804) in advanced/metastatic squamous cell carcinoma of the penis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Neoplasms
• Squamous Cell Carcinoma of the Penis

Drugs mentioned

• Dacomitinib (dacomitinib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Penile Neoplasms, Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED